The story of Viagra, formerly marketed by copyright, presents a fascinating case study for stakeholders considering the healthcare arena . Although its initial success and impact of vast in revenue , the exclusivity expiration has opened the floodgates for generic medications, substantially diminishing income prospects . This shift raises questions